N. Willmott
Impact in
- Pharmaceutical Science top 1%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Advancements in Transdermal Drug Delivery
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
-
- Protein Interaction Studies and Fluorescence Analysis 6
- Oncology 19
- Cancer Treatment and Pharmacology 10
- Co-authors
- Jeffrey L. Cummings (15 shared papers)Alastair J. Florence (8 shared papers)John F. Smyth (7 shared papers)CS McArdle (12 shared papers)DJ Kerr (8 shared papers)Alan Rogerson (1 shared paper)J. H. McKillop (8 shared papers)Lorraine Anderson (1 shared paper)
- Journals
- British Journal of Cancer (9 papers)Biochemical Pharmacology (7 papers)Journal of Pharmacy and Pharmacology (4 papers)Nuclear Medicine Communications (3 papers)Journal of Controlled Release (3 papers)
- Partner nations
- United KingdomUnited StatesJapan
In The Last Decade
N. Willmott
64 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 97
- Pharmaceutical Science 326
- Hepatology 137
- Biomaterials 237
- Oncology 384
- Toxicology 51
Countries citing papers authored by N. Willmott
This map shows the geographic impact of N. Willmott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Willmott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Willmott more than expected).
Fields of papers citing papers by N. Willmott
This network shows the impact of papers produced by N. Willmott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Willmott. The network helps show where N. Willmott may publish in the future.
Co-authors
The 25 scholars most cited alongside N. Willmott, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 66 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1988 | 147 | |
| 2 | 1991 | 135 | |
| 3 | 1985 | 96 | |
| 4 | 1987 | 69 | |
| 5 | 1988 | 65 | |
| 6 | 1997 | 58 | |
| 7 | 1992 | 41 | |
| 8 | 1986 | 41 | |
| 9 | 1992 | 38 | |
| 10 | 1989 | 38 | |
| 11 | 1991 | 38 | |
| 12 | 1992 | 37 | |
| 13 | 1987 | 33 | |
| 14 | 1988 | 32 | |
| 15 | 1991 | 30 | |
| 16 | 1996 | 28 | |
| 17 | 1988 | 27 | |
| 18 | 2008 | 25 | |
| 19 | 1985 | 25 | |
| 20 | 1995 | 22 |
About N. Willmott
N. Willmott is a scholar working on Molecular Biology, Oncology, Pharmaceutical Science, Pulmonary and Respiratory Medicine and Biomaterials, having authored 66 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (10 papers), Nanoparticle-Based Drug Delivery (10 papers), Advanced Drug Delivery Systems (10 papers), Chemotherapy-induced cardiotoxicity and mitigation (9 papers), Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Lanthanide and Transition Metal Complexes (6 papers), Protein Interaction Studies and Fluorescence Analysis (6 papers) and Cancer Research and Treatments (6 papers). The work is most often cited by research in Pharmaceutical Science (326 citations), Hepatology (137 citations), Biomaterials (237 citations), Oncology (384 citations) and Toxicology (51 citations). N. Willmott has collaborated with scholars based in United Kingdom, United States and Japan. Frequent co-authors include Jeffrey L. Cummings, Alastair J. Florence, John F. Smyth, CS McArdle, DJ Kerr, Alan Rogerson, J. H. McKillop, Lorraine Anderson, Joseph C. Anderson and Yan Chen. Their work appears in journals such as British Journal of Cancer, Biochemical Pharmacology, Journal of Pharmacy and Pharmacology, Nuclear Medicine Communications and Journal of Controlled Release.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.